Pharmaceutical

Japan approves updated Covid-19 vaccine to tackle JN.1 variant

Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a planned October 2024 Covid-19 vaccination campaign.

Sep 14, 2024 - 04:00
Japan approves updated Covid-19 vaccine to tackle JN.1 variant
Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a planned October 2024 Covid-19 vaccination campaign.
Read the original article

Tags:

Previous Article

Tern’s oral GLP-1 achieves 5% weight reduction within one month at the highest dose

Next Article

Oncternal stock crashes by 60% as it lays off staff and scraps trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Obesity impairs brain responses to nutrients, even after weight loss, study finds

Obesity impairs brain responses to nutrients, even afte...

Jun 12, 2023

Sterilisation Solutions, Equipment and Services for the Pharmaceutical Industry

Sterilisation Solutions, Equipment and Services for the...

Oct 2, 2024

Lilly to acquire biopharma firm Versanis for $1.9bn

Lilly to acquire biopharma firm Versanis for $1.9bn

Jul 17, 2023